Cleveland OH 淋巴瘤临床试验
13项针对 淋巴瘤的研究正在 Cleveland及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
招募中2 期
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- The Cleveland Clinic Foundation, Cleveland
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
招募中2 期
- University Hospitals Cleveland Medical Center, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Cleveland Clinic, Cleveland
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
招募中3 期
- Research Site, Cleveland
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
招募中1/2 期
- University Hospitals Seidman Cancer Center, Cleveland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
招募中1 期
- University Hospitals Cleveland Medical Center, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Cleveland Clinic, Cleveland
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
招募中1/2 期
- Cleveland Clinic, Cleveland
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
招募中1 期
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Cleveland Clinic, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
招募中1 期
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
其他城市的 淋巴瘤试验
- Houston, TX34 项研究
- Boston, MA34 项研究
- New York City, NY33 项研究
- Washington, DC23 项研究
- Baldwin Park, CA22 项研究
- Chicago, IL19 项研究
- Durham, NC17 项研究
- St. Louis, MO15 项研究
- Seattle, WA13 项研究
- Atlanta, GA13 项研究
- Philadelphia, PA13 项研究
- Edison, NJ12 项研究
Cleveland的其他研究
- 非小细胞肺癌48 项研究
- 癌症（所有类型）36 项研究
- 乳腺癌33 项研究
- 心力衰竭31 项研究
- 转移性癌症30 项研究
- 前列腺癌30 项研究
- 卵巢癌29 项研究
- 肺癌26 项研究
- 结直肠癌25 项研究
- 急性髓系白血病20 项研究
- 头颈鳞状细胞癌20 项研究
- 心血管疾病20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。